
Tina M. Patterson
Articles
-
Oct 30, 2024 |
ajp.com.au | Megan Haggan |Vincent Chua |Gavin McKay |Tina M. Patterson
In a move welcomed by pharmacists, the NSW Government has reached an agreement to increase wages and benefits for more than 50,000 health workers The agreement, with the Health Services Union, covers allied health roles, hospital cleaners, scientists, security officers, patient transport officers and more. Under the state government’s new Fair Pay and Bargaining Policy,This content is restricted to registered users only.
-
Oct 30, 2024 |
ajp.com.au | Nicholas O’Donoghue |Vincent Chua |Gavin McKay |Tina M. Patterson
Bank urges caution following scam scare Pharmacy owners are being advised to keep an eye out for red flags for potential scams, by the National Australia Bank (NAB). Following an alert released by the Pharmacy Guild of Australia’s Queensland branch warning that criminals impersonating bank staff have been “actively” targeting community pharmacies, Laura Hartley, NAB’sThis content is restricted to registered users only.
-
Oct 30, 2024 |
ajp.com.au | Nicholas O’Donoghue |Vincent Chua |Gavin McKay |Tina M. Patterson
Pharmacy sector welcomes Covid-19 Response Inquiry Report’s call for action on full scope of practice The Covid-19 Response Inquiry Report is calling for nationally consistent reforms “to allow health professionals to work to their full training and experience” to be implemented within the next 18 months. The report, released on Tuesday (29 October 2024) includedThis content is restricted to registered users only.
-
Oct 30, 2024 |
ajp.com.au | Megan Haggan |Gavin McKay |John Smith |JOhn Smith |Tina M. Patterson
The general public has again been reminded that ivermectin is prescription-only and should not be independently imported from overseas The Therapeutic Goods Administration has issued a third warning pointing out that it continues to see imports of counterfeit ivermectin. The first two warnings, in December 2021 and March 2022, advised Australians that there is insufficientThis content is restricted to registered users only.
-
Oct 29, 2024 |
ajp.com.au | Nicholas O’Donoghue |Tina M. Patterson |Erin Michelle Threlfall |Tim Hewitt
Pharmaceutical company defends switch to home delivery service to manage supply shortages of one of its products Constrained supply of Pegasys (peginterferon alfa-2a) due to “unusual large orders, suspected to be deemed for export” is behind Echo Therapeutics’ decision to change its distribution system for the medication. In a statement to the AJP, Jude D’SilvaThis content is restricted to registered users only.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →